Rainbow Childrens Medicare growth over the years

Profitability Growth Credit Liquidity Working capital Dividend yield DuPont CAGR

Compounded a year	1 yr	3 yr
Revenue	+12.4%	+13.2%
EBITDA	+11.1%	+11.1%
Net Income	+15.3%	+9.9%
EPS (adj.)	+14.3%	+9.7%
Total Assets	+16.8%	+16.0%
Total Equity	+12.8%	+16.0%
Free Cash Flow	−18.7%	+3.0%

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

RAINBOW₹1,196.80

Rainbow Childrens Medicare Ltd.

· Pharma & Health

₹ CrorePeersAPOLLOHOSP FORTIS KIMS POLYMED PFIZER ONESOURCE JUBLPHARMA VIJAYAMcap ₹12,155 Cr

Annuals · FY-end closes

Compounded Growth Annuals · CAGR %	1Y CAGR	3Y CAGR
Revenue	+12.4	+13.2
EBITDA	+11.1	+11.1
Net Income	+15.3	+9.9
EPS (adj.)	+14.3	+9.7
Total Assets	+16.8	+16.0
Total Equity	+12.8	+16.0
Free Cash Flow	-18.7	+3.0

CAGR from filed annuals — needs positive start & end values.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.